Phase II trial of low-dose cyclo-phosphamide, leucovorin, high-dose 5-fluorouracil 24-hour continuous infusion and tamoxifen in advanced biliary tract cancer [2]

F. Eckel, C. Lersch, G. Assmann, E. Schulte-Frohlinde

Research output: Contribution to journalLetterpeer-review

10 Scopus citations
Original languageEnglish
Pages (from-to)762-763
Number of pages2
JournalAnnals of Oncology
Volume11
Issue number6
DOIs
StatePublished - 2000
Externally publishedYes

Cite this